Skip to content

Psilocybin-assisted psychotherapy for people with cancer: a scoping review of intervention components, psychotherapeutic frameworks, and models of delivery

Suzanne Grant, Maria González, Hannah Adler

OSF Preprints October 7, 2026 preprint DOI: 10.17605/osf.io/hvwtm (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Scoping review Qualitative
Population People with cancer
Intervention Psilocybin-assisted psychotherapy
Topics Psilocybin Psychedelic-assisted therapy
Key findings The review sets out to map the extent, range, and types of evidence on psilocybin-assisted psychotherapy in people with cancer, including which psychotherapies are used, how therapy is delivered, and associated outcomes reported in qualitative and quantitative studies. No results or conclusions are reported in the abstract.

Abstract

The objective of this scoping review is to map the extent, range, and types of evidence related to psilocybin-assisted psychotherapy in people with cancer, including the types of psychotherapy used, models of delivering therapy, and associated outcomes, as reported in qualitative and quantitative studies.

In the evidence

This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.

Comparable studies

Other narrative reviews on psilocybin and psychedelic-assisted therapy, most cited first.

Explore topics

By condition and practice